The Benzene Metabolites Hydroquinone and Catechol Act in Synergy to Induce Dose-Dependent Hypoploidy and -5q31 in a Human Cell Line

References

• Santesson C. G. Chronic poisoning with coal tar benzene: Four deaths. Clinical and pathological-anatomical observations of several colleagues and illustrating animal experiments. Archiv fur Hygiene 1897; 31: 336–376
   Google Scholar
• Greenburg L., Mayers M. R., Goldwater L. J., Smith A. R. Benzene (benzol) poisoning in the rotogravure printing industry in New York City. Journal of Industrial Hygiene and Toxicology 1939; 21(8)395–420
   Google Scholar
• Laskin S., Goldstein B. D. Benzene toxicity: a critical evaluation. Journal of Toxicology and Environmental Health. 1977; 2: 1–148
   Google Scholar
• Vigliani E. C., Saita G. Benzene and leukemia. New England Journal of Medicine 1964; 271: 872–876
   PubMed Web of Science ®Google Scholar
• Vigliani E. C., Fomi A. Benzene and leukemia. Environmenral Research 1976; 11: 122–127
   PubMed Web of Science ®Google Scholar
• Aksoy M., Erdem S., Dinçol K., Hepyüksel T., Dinçol G. Chronic exposure to benzene as a possible contributary etiologic factor in Hodgkin's Disease. Blut 1974; 28: 293–298
   PubMedGoogle Scholar
• Aksoy M., Erdem S., Dinçol G. Types of leukemia in chronic benzene poisoning: a study in my-four patients. Acta Haematologica 1976; 55: 65–72
   PubMed Web of Science ®Google Scholar
• Infante P. F., Rinsky R. A., Wagoner J. K., Young R. J. Leukaemia in benzene workers. Lancet 1977; 2: 76–78
   PubMed Web of Science ®Google Scholar
• Casciato D. A., Scott J. L. Acute leukemia following prolonged cytotoxic agent therapy. Medicine 1979; 58(1)32–47
   PubMed Web of Science ®Google Scholar
• Foucar K., McKenna R. W., Bloomfield C. D., Bowers T. K., Brunning R. D. Therapy-related leukemia. Cancer 1979; 43: 1285–1296
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J., Philip P., Moansen B. T., Ersboll J., Jensen G., Panduro J., Thomsen M. Acute nonlymphocytic leukemia, preleukemia. and acute myelopro-liferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing. Blood 1981; 57(4)712–723
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J., Pedersen M., Roulston D., Philip P. Different genetic pathways in leukemogene-sis for patients presenting with therapy-related myelodyspla-sia and therapy-related acute myeloid leukemia. Blood 1995; 86: 3542–3552
   PubMed Web of Science ®Google Scholar
• Anderson R. L., Bagby G. C., Jr., Richert-Boe K., Magenis R. E., Koler R. D. Therapy-related preleukemic syndrome. Cancer 1981; 47: 1867–1871
   PubMed Web of Science ®Google Scholar
• Coltman C. A., Dahlberg S. Treatment-related leukemia. New England Journal of Medicine 1990; 322: 52–53
   PubMed Web of Science ®Google Scholar
• Advani S. H., Doval D. C., Gopal R., Nair C. N., Kutty P. M. Therapy-related leukemia. Oncology 1983; 40: 268–272
   PubMed Web of Science ®Google Scholar
• Rowley J. D., Golomb H. M., Vardiman J. Non-random chromosomal abnormalities in acute nonlymphocytic leukemia in patients treated for Hodgkin's disease and non-Hodgkin lymphomas. Blood 1977; 50: 759–770
   Web of Science ®Google Scholar
• Rowley J. D., Golomb H. M., Vardiman J. W. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood 1981; 58: 759–767
   PubMed Web of Science ®Google Scholar
• Le Beau M. M., Albain K. S., Larson R. A., Vardiman J. W., Davis E. M., Blough R. R., Golomb H. M., Rowley J. D. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. Journal of Clinical Oncology 1986; 4(3)325–345
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J., Philip P., Perdersen N. T., Hou-Jensen K., Svejgaard A., Jensen G., Nissen N. I. Acute nonlymphocytic leukemia, preleukemia. and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Cancer 1984; 54: 452–462
   PubMed Web of Science ®Google Scholar
• Johansson B., Mertens F., Heim S., Kristoffersson U., Mitelman F. Cytogenetics of secondary myelodyspla-sia (sMDS) and acute nonlymphocytic leukemia (sANLL). European Journal of Haemarology 1991; 47: 17–27
   PubMed Web of Science ®Google Scholar
• Bitter M. A., Le Beau M. M., Rowley J. D., Larson R. A., Golomb H. M., Vardiman J. W. Associations between morphology, karyotype, and clinical features in myeloid leukemias. Human Pathology 1987; 18: 211–225
   PubMed Web of Science ®Google Scholar
• Fourth International Workshop on Chromosomes in Leukemia. The correlation of karyotype and occupational exposure to potential mutagenidcarcinogenic agents in acute nonlymphocytic leukemia. Cancer Genetics and Cytogenetics 1984; 11: 326–331, 1982
   PubMedGoogle Scholar
• Bloomfield C. D., Goldman A., Hossfeld D., de la Chapelle A. Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia. Cancer Genetics and Cytogenetics 1984; 11: 332–350
   PubMedGoogle Scholar
• Mitelman F., Nilsson P. G., Brandt L., Alimena G., Gastaldi R., Dallapiccola B. Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genetics and Cytogenetics 1981; 4: 197–214
   PubMed Web of Science ®Google Scholar
• Mitelman F., Brandt L., Nilsson P. G. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood 1978; 52: 1229–1237
   PubMed Web of Science ®Google Scholar
• Fagioli F., Cuneo A., Piva N., Carli M. G., Previati R., Balboni M., Tomasi P., Cariani D., Scapoli G., Castoldi G. Distinct cytogenetic and clinicopatho-logic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents. Cancer 1992; 70: 77–85
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Alimena G., Rowley J. D., Vardiman J. W., Testa J. R., Sovik C. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood 1982; 60: 404–411
   PubMed Web of Science ®Google Scholar
• Cuneo A., Fagioli E, Pazzi I., Tallarico A., Previati R., Piva N., Carli G. M., Balboni M., Castoldi G. Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents. Leukemia Research 1992; 16: 789–796
   PubMed Web of Science ®Google Scholar
• Narod S. A., Dube I. D. Occupational history and involvement of chromosomes 5 and 7 in acute nonlymphocytic leukemia. Cancer Genetics and Cyrogenetics 1989; 38: 261–269
   PubMed Web of Science ®Google Scholar
• Crane M. M., Keating M. J., Trujillo J. M., Labarthe D. R., Frankowski R. F. Environmental exposures in cytogenetically defined subsets of acute nonlymphocytic leukemia. Journal of the American Medical Association 1989; 262: 634–639
   PubMed Web of Science ®Google Scholar
• Van den Berghe H., Louwagie A., Broeckaert-Van Orshoven A., David G., Verwilghen R. Chromosome analysis in two unusual malignant blood disorders presumably induced by benzene. Blood 1979; 53: 558–566
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Fearon E. R., Hamilton S. R., Kern S. E., Pre-Isinger A. C., Leppert M., Nakamura Y., White R., Smits A. M. M., Bos J. L. Genetic alterations during col-orectal-tumor development. New England Journal of Medicine 1988; 319(9)525–532
   PubMed Web of Science ®Google Scholar
• Irons R. D. Leukemogenesis as a toxic response. Comprehensive Toxicology, I. G. Sipes, C. A. McQueen, A. J. Gandolfi, J. C. Bloom. Elsevier Science Ltd., New York 1997; 175–199
   Google Scholar
• Irons R. D., Stillman W. S. The process of leukemogenesis. Environmental Health Perspectives 1996; 104: 1239–1246, Suppl. 6
   PubMed Web of Science ®Google Scholar
• Andrews L. S., Lee E. W., Witmer C. M., Kocsis J. J., Snyder R. S. Effects of toluene on the metabolism, disposition and hemopoietic toxicity of benzene. Biochemical Pharmacology 1977; 26: 293–300
   PubMed Web of Science ®Google Scholar
• Andrews L. S., Sasame H. A., Gillette J. R. 3H-benzene metabolism in rabbit bone marrow. Life Sciences 1979; 25: 567–712
   PubMed Web of Science ®Google Scholar
• Sammett D., Lee E. W., Kocsis J. J., Snyder R. Partial hepatectomy reduced both metabolism and toxicity of benzene. Journal of Toxicology and Environmental Health 1979; 5: 785–792
   PubMed Web of Science ®Google Scholar
• Eastmond D. A., Smith M. T., Irons R. D. An interaction of benzene metabolites reproduces the myelotox-icity observed with benzene exposure. Toxicology and Applied Pharmacology 1987; 91: 85–95
   PubMed Web of Science ®Google Scholar
• Rickert D. E., Baker T. S., Bus J. S., Barrow C. S., Irons R. D. Benzene disposition in the rat after exposure by inhalation. Toxicology and Applied Pharmacology 1979; 49: 417–423
   PubMed Web of Science ®Google Scholar
• Wierda D., Irons R. D. Hydroquinone and cate-chol reduce the frequency of progenitor B lymphocytes in mouse spleen and bone marrow. Immunopharmacology 1982; 4: 41–54
   PubMed Web of Science ®Google Scholar
• Irons R. D. Quinones as toxic metabolites of benzene. Journal of Toxicology and Environmental Health 1985; 16: 673–678
   PubMed Web of Science ®Google Scholar
• Tice R. R., Costa D. L., Drew R. T. Cytogenetic Effects of Inhaled Benzene in Murine Bone Marrow: Induction of Sister Chromatid Exchanges, Chromosomal Aberrations, and Cellular Proliferation Inhibition in DBA/2 Mice. Proceedings of the National Academy of Sciences of the United States of America 1980; 77(4)2148–2152
   PubMed Web of Science ®Google Scholar
• Luke C. A., Tice R. R., Drew R. T. The Effect of Gender and Exposure Regimen and Duration on Benzene-Induced Bone Marrow Damage. Environmental Health Perspectives 1989; 82: 65–74
   PubMed Web of Science ®Google Scholar
• Fomi A., Moreo L. Chromosome Studies in a Case of Benzene-Induced Erythroleukaemia. European Journal of Cancer 1969; 5: 459–463
   PubMed Web of Science ®Google Scholar
• Fomi A. Chromosome changes and benzene exposure. A review. Reviews on Environmental Health 1979; 3: 5–17
   PubMed Web of Science ®Google Scholar
• Morimoto K. Analysis of Combined Effects of Benzene With Radiation on Chromosomes in Cultured Human Leukocytes. Japanese Journal of Industrial Health 1976; 18: 23–34
   PubMedGoogle Scholar
• Tsutsui T., Nayashi N., Maizuni H., Huff J., Barren J. C. Benzene-, catechol-, hydroquinone- and phenol-induced cell transformation, gene mutations, chromosome aberrations, aneuploidy. sister chromatid exchanges and unscheduled DNA synthesis in Syrian hamster embryo cells. Mutation Research 1997; 373: 113–123
   PubMed Web of Science ®Google Scholar
• Muirhead K. A., Irons R. D., Bruns R., Horan P. K. A rabbit bone marrow model system for evaluation of cytotoxicity: characterization of normal bone marrow cell cycle parameters by flow cytometry. Journal of Histochemistry and Cytochemistry 1980; 28(6)526–532
   PubMed Web of Science ®Google Scholar
• Horan P. K., Muirhead K. A., Gorton S., Irons R. D. Aseptic aspiration of rabbit bone marrow and enrichment for cycling cells. Laboratory Animal Science 1980; 30(1)76–79
   PubMedGoogle Scholar
• Irons R. D. Benzene-induced myelotoxicity: application of flow cytofluorometry for the evaluation of early pro-liferative change in bone marrow. Environmental Health Perspectives 1981; 39: 39–49
   PubMed Web of Science ®Google Scholar
• Irons R. D., Neptun D. A., Pfeifer R. W. lnhibition of lymphocyte transformation and microtubule assembly by quinone metabolites of benzene: evidence for a common mechanism. Journal of the Reticuloendothelial Society. 1981; 30(5)359–372
   PubMedGoogle Scholar
• Irons R. D., Neptun D. A. Effects of the principal hydroxymetabolites of benzene on microtubule polymerization. Archives of Toxicology 1980; 45: 297–305
   PubMed Web of Science ®Google Scholar
• Irons R. D., Pfeifer R. W., Aune T. M., Pierce C. W. Soluble immune response suppressor (sirs) inhibits microtubule function in vivo and microtubule assembly in vitro. Journal of mmunology 1984; 133: 2032–2036
   PubMed Web of Science ®Google Scholar
• Yager J. W., Eastmond D. A., Robertson M. L., Pardisin W. M., Smith M. T. Characterization of micronu-clei induced in human lymphocytes by benzene metabolites. Cancer Research 1990; 50: 393–399
   PubMed Web of Science ®Google Scholar
• Marrazzini A., Chelotti L., Barrai I., Loprieno N., Barale R. In vivo genotoxic interactions among three phenolic benzene metabolites. Mutat. Res. Genet. Toxicol. Testing 1994; 341: 29–46
   PubMed Web of Science ®Google Scholar
• Stillman W. S., Varella-Garcia M., Gruntmeir J. J., Irons R. D. The benzene metabolite, hydroquinone. induces dose-dependent hypoploidy in a human cell line. Leukemia 1997; 11: 1540–1545
   PubMed Web of Science ®Google Scholar
• Robertson M. L., Eastmond D. A., Smith M. T. Two benzene metabolites, catechol and hydroquinone, produce a synergistic induction of micronuclei and toxicity in cultured human lymphocytes. Mutation Research 1991; 249: 201–209
   PubMed Web of Science ®Google Scholar
• Levay G., Bodell W. J. Potentiation of DNA adduct formation in HL-60 cells by combinations of benzene metabolites. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 7105–7109
   PubMed Web of Science ®Google Scholar
• Natarajan A. T., Tates A. D., Meijers M., Neuteboom M., Vogel N. Induction of sister chromatid exchanges (SCEs) and chromosomal aberrations by mitomycin C and methyl methanosulfonate in Chinese hamster oveary cells. Mutation Research 1983; 121: 211–223
   PubMed Web of Science ®Google Scholar
• Preston R. J., Dean B. J., Galloway S., Holden H., McFee A. F., Shelby M. Mammalian in vivo cytogenetic assays: analysis of chromosome aberrations in bone marrow cells. Mutation Research 1987; 189: 157–165
   PubMed Web of Science ®Google Scholar
• Cox D. M., Puck T. T. Chromosomal non-disjunction: the action of colcemid on Chinese hamster cells in vitro. Cytogenerics 1969; 8: 158–169
   PubMedGoogle Scholar
• Draper N. P., Smith H. Applied Regression Analysis. John Wiley & Sons, New York 1981
   Google Scholar
• Fairman J., Chumakov I., Chinault A. C., Nowell P. C., Nagarajan L. Physical mapping of the minimal region of loss in 5q-chromosome. Proceedings of the. National Academy of Sciences of the United States of America 1995; 92: 7406–7410
   PubMed Web of Science ®Google Scholar
• Le Beau M. M., Espinosa R., III, Neuman W. L., Stock W., Roulston D., Larson R. A., Keinanen M., Westbrook C. A. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proceedings of the National Academy of Sciences of the United Stares of America 1993; 90: 5484–5488
   PubMed Web of Science ®Google Scholar
• Homgan S. K., Westbrook C. A., Kim A. H., Banerjee M., Stock W., Larson R. A. Polymerase chain reaction-based diagnosis of Del(5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood 1996; 88: 2665–2670
   PubMed Web of Science ®Google Scholar
• Van den Berghe H., Vermaelen K., Mecucci C., Barbieri D., Tricot G. The 5q- anomaly. Cancer Genetics and Cyrogenetics 1985; 17: 189–225
   PubMed Web of Science ®Google Scholar
• Eastmond D. A., Schuler M., Rupa D. S. Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutation Research 1995; 348: 153–162
   PubMed Web of Science ®Google Scholar
• Eastmond D. A., Rupa D. S., Hasegawa L. S. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutation Research 1994; 322: 9–20
   PubMed Web of Science ®Google Scholar
• Lee S. -F., Lin J. -K. Generation of hydrogen peroxide, superoxide anion and the hydroxyl free radical from polyphenols and active benzene metabolites: Their possible role in mutagenesis. J. Biomed. Sci 1994; 1: 125–130
   PubMedGoogle Scholar
• Irons R. D., Stillman W. S. Cell proliferation and differentiation in chemical leukemogenesis. Stem Cells. 1993; 11: 235–242
   PubMed Web of Science ®Google Scholar
• Irons R. D., Stillman W. S. Impact of benzene metabolites on differentiation of bone marrow progenitor cells. Environmental Health Perspectives 1996; 104: 1247–1250, Suppl. 6
   PubMed Web of Science ®Google Scholar